Skip to main content

Table 3 Frequency of symptoms referred by SARS-CoV-2-positive employees of the University of Padua. Positive subjects comprised 84 individuals identified by surveillance salivary testing and 78 individuals who directly underwent NPS for suspected clinical manifestations

From: The University of Padua salivary-based SARS-CoV-2 surveillance program minimized viral transmission during the second and third pandemic wave

 

Saliva-based diagnosis (n=84)

NPS-based diagnosis (n=78)

Chi-square

p-value

Fever

26 (31%)

45 (58%)

11.7465

p = 0.001

Anosmia

12 (14%)

15 (19%)

0.7121

p = 0.399

Ageusia

7 (8%)

15 (19%)

4.0925

p = 0.043

Asthenia

20 (24%)

25 (32%)

1.3694

p = 0.242

Cough

17 (20%)

21 (27%)

1.0067

p = 0.316

Headache

11 (13%)

17 (22%)

2.1411

p = 0.143

Gastrointestinal symptoms

0

4 (5%)

4.4167

p = 0.036

Arthralgia

5 (6%)

9 (12%)

1.5985

p = 0.206

Myalgia

8 (10%)

13 (17%)

1.8289

p = 0.176

Dyspnea

2 (2%)

2 (3%)

0.0056

p = 0.940

Rhinitis

24 (29%)

21 (27%)

0.0548

p = 0.815

Sore throat

12 (15%)

11 (14%)

0.0092

p = 0.924